The Journal of Urology
Volume 182, Issue 6, Supplement , Pages S32-S37, December 2009

Diabetes and Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms—What do We Know?

  • Aruna V. Sarma

      Affiliations

    • Department of Epidemiology, University of Michigan, Ann Arbor, Michigan
    • Corresponding Author InformationCorrespondence: Departments of Urology and Epidemiology, University of Michigan, Room 1025, Michigan House, 2301 Commonwealth Blvd., Ann Arbor, Michigan 48105-2967 (telephone: 734-763-7514; FAX: 734-232-2400)
  • ,
  • J. Kellogg Parsons

      Affiliations

    • Department of Urology, University of California-San Diego, San Diego, California
    • Financial interest and/or other relationship with American Medical Systems.
  • ,
  • Kevin McVary

      Affiliations

    • Department of Urology, Northwestern University, Chicago, Illinois
    • Financial interest and/or other relationship with GlaxoSmithKline, Pfizer, Lilly/ICOS, Sanovi Aventis, Allergan and National Institutes of Diabetes and Digestive and Kidney Diseases.
  • ,
  • John T. Wei

      Affiliations

    • University of Michigan, Department of Urology, Ann Arbor, Michigan
    • Financial interest and/or other relationship with Sanofi, American Medical Systems, Envisioneering, Gen-Probe and Beckman.

published online 20 October 2009.

Purpose

Benign prostatic hyperplasia and associated lower urinary tract symptoms are highly prevalent in older men and represent a substantial challenge to public health. Apart from the prevalence of benign prostatic hyperplasia increasing with age, little is understood regarding its etiology and natural history. Increasing evidence recently pointed toward relationships between diabetes and benign prostatic hyperplasia/lower urinary tract symptoms. We present an overview of the current understanding of clinical and epidemiological research on diabetes and benign prostatic hyperplasia/lower urinary tract symptoms, the hypothesized pathophysiological mechanisms linking the conditions and recommendations for future directions for research.

Materials and Methods

A structured, comprehensive literature review was done to identify studies of the relationships between benign prostatic hyperplasia and lower urinary tract symptoms, and diabetes in older men.

Results

A substantial proportion of the existing body of literature supports an association between diabetes and benign prostatic hyperplasia/lower urinary tract symptoms. However, failure to differentiate lower urinary tract symptoms from benign prostatic hyperplasia contributed to some of the confusing evidence in studies including more specific benign prostatic hyperplasia measurements. This could be due in part to the largely cross-sectional analyses, the use of select or different study populations, limited sample sizes and inadequate control of potential confounders.

Conclusions

Diabetes may substantially influence the risk of benign prostatic hyperplasia and lower urinary tract symptoms in older men. Further prospective, longitudinal analyses of the impact of diabetes and its etiological mechanisms on benign prostatic hyperplasia/lower urinary tract symptoms may identify novel interventions to prevent, diagnose and treat these highly prevalent conditions.

Key Words: urinary tract, prostatic hyperplasia, diabetes mellitus, aging, urination disorders

Abbreviations and Acronyms: BPH, benign prostatic hyperplasia, IGF, insulin-like growth factor, I-PSS, International Prostate Symptom Score, LUTS, lower urinary tract symptoms

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-5347(09)01904-1

doi:10.1016/j.juro.2009.07.088

The Journal of Urology
Volume 182, Issue 6, Supplement , Pages S32-S37, December 2009